Real-World Data on Newly Diagnosed -Mutated High-Grade Epithelial Ovarian Cancers: The French National Multicenter ESME Database.
Fiche publication
Date publication
août 2022
Journal
Cancers
Auteurs
Membres identifiés du Cancéropôle Est :
Pr MARCHAL Frédéric, Dr DEMARCHI Martin
Tous les auteurs :
Bini M, Quesada S, Meeus P, Rodrigues M, Leblanc E, Floquet A, Pautier P, Marchal F, Provansal M, Campion L, Causeret S, Gourgou S, Ray-Coquard I, Classe JM, Pomel C, De La Motte Rouge T, Barranger E, Savoye AM, Guillemet C, Gladieff L, Demarchi M, Rouzier R, Courtinard C, Romeo C, Joly F
Lien Pubmed
Résumé
In spite of the frequency and clinical impact of alterations in high-grade epithelial ovarian cancer (HGEOC), real-world information based on robust data warehouse has been scarce to date.
Mots clés
BRCA1, BRCA2, epidemiological strategy and medical economics database, epidemiology, high-grade epithelial ovarian cancer, overall survival, platinum-based chemotherapy, progression-free survival, real-world data, treatment patterns
Référence
Cancers (Basel). 2022 08 21;14(16):